Amarin Corp Plc (AMRN)

[dogn]

Amarin makes moves towards global expansion of Vazkepa

September 22, 2022

The company has its eye on being included in China’s National Reimbursement Drug List. Abuaf explains, “This would be a massive milestone because cardiovascular disease is also touching a massive number of patients in big geographies like China.”

In reference to the company’s hopes for the future and its current plans for Vazkepa, Abuaf says, “We’re trying to make the most of the environment in a smart way, putting together what we know and what we understand. Most of the time, it works. Sometimes we hit a wall, like in Germany, but overall, it’s overwhelmingly progressing well.”

https://www.pharmaceutical-technology.com/news/amarin-makes-moves-towards-global-expansion-of-vazkepa/